
|
|  | |
|
Am J Psychiatry 1992; 149:464-469
Copyright © 1992 by American Psychiatric Association
Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults
N Breslau, MM Kilbey and P Andreski
Department of Psychiatry, Henry Ford Hospital, Ann Arbor, MI.
OBJECTIVE: Earlier, the authors reported on the association of nicotine
dependence with major depression and anxiety disorders in a group of young
adults. This report describes the occurrence of withdrawal symptoms and
their sociodemographic and psychiatric correlates in persons in that group
who tried unsuccessfully to abstain from smoking. METHOD: A random sample
of 1,007 members of a health maintenance organization, 21-30 years old,
were interviewed with a revised version of the NIMH Diagnostic Interview
Schedule. Data on nicotine withdrawal came from a subset of 239 smokers who
had tried unsuccessfully to quit or cut down on smoking. RESULTS: With two
exceptions, each of the DSM- III-R nicotine withdrawal symptoms was
reported by more than one-half of these smokers. Withdrawal symptoms were
more severe in white than in black smokers but were unrelated to sex,
educational level, or marital status. Persons with histories of major
depression or any anxiety disorder reported more severe withdrawal symptoms
than persons with neither of these disorders. Severity of withdrawal, or
any specific symptom, did not account for the association between major
depression and continued smoking. Furthermore, severity of withdrawal was
unrelated to continued smoking. CONCLUSIONS: While the long-term clinical
significance of nicotine withdrawal is unclear, the evidence indicates that
in the general population, abstinence from smoking is associated with a
variety of disturbances, including a craving for cigarettes, dysphoria, and
symptoms of irritability or nervousness. In this study disturbances were
more severe in persons with histories of major depression or anxiety
disorders.
This article has been cited by other articles:

|
 |

|
 |
 
K. Hill, R. Geist, R. S. Goldstein, and Y. Lacasse
Anxiety and depression in end-stage COPD
Eur. Respir. J.,
March 1, 2008;
31(3):
667 - 677.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Rasmusson, M. R. Picciotto, and S. Krishnan-Sarin
Smoking as a complex but critical covariate in neurobiological studies of posttraumatic stress disorders: a review
J Psychopharmacol,
September 1, 2006;
20(5):
693 - 707.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. V. Prochazka, S. Kick, C. Steinbrunn, T. Miyoshi, and G. E. Fryer
A Randomized Trial of Nortriptyline Combined With Transdermal Nicotine for Smoking Cessation
Arch Intern Med,
November 8, 2004;
164(20):
2229 - 2233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R Erickson, L. A Thomas, S. G Blitz, and L. R Pontius
Smoking Cessation: A Pilot Study of the Effects on Health-Related Quality of Life and Perceived Work Performance One Week into the Attempt
Ann. Pharmacother.,
November 1, 2004;
38(11):
1805 - 1810.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Neu, P. Schlattmann, A. Schilling, and A. Hartmann
Cerebrovascular Reactivity in Major Depression: A Pilot Study
Psychosom Med,
January 1, 2004;
66(1):
6 - 8.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. el-Guebaly, J. Cathcart, S. Currie, D. Brown, and S. Gloster
Public Health and Therapeutic Aspects of Smoking Bans in Mental Health and Addiction Settings
Psychiatr Serv,
December 1, 2002;
53(12):
1617 - 1622.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. S. Covey, A. H. Glassman, F. Stetner, S. Rivelli, and K. Stage
A Randomized Trial of Sertraline as a Cessation Aid for Smokers With a History of Major Depression
Am J Psychiatry,
October 1, 2002;
159(10):
1731 - 1737.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. da Costa, R. N. Younes, and M. T. C. Lourenco
Stopping Smoking* : A Prospective, Randomized, Double-Blind Study Comparing Nortriptyline to Placebo
Chest,
August 1, 2002;
122(2):
403 - 408.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Tibbs and D. Haire-Joshu
Avoiding High-Risk Behaviors: Smoking Prevention and Cessation in Diabetes Care
Diabetes Spectr,
July 1, 2002;
15(3):
164 - 169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Carney, K. E. Freedland, R. C. Veith, and A. S. Jaffe
Can Treating Depression Reduce Mortality After an Acute Myocardial Infarction?
Psychosom Med,
September 1, 1999;
61(5):
666 - 675.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. V. Prochazka, M. J. Weaver, R. T. Keller, G. E. Fryer, P. A. Licari, and D. Lofaso
A Randomized Trial of Nortriptyline for Smoking Cessation
Arch Intern Med,
October 12, 1998;
158(18):
2035 - 2039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Hall, V. I. Reus, R. F. Munoz, K. L. Sees, G. Humfleet, D. T. Hartz, S. Frederick, and E. Triffleman
Nortriptyline and Cognitive-Behavioral Therapy in the Treatment of Cigarette Smoking
Arch Gen Psychiatry,
August 1, 1998;
55(8):
683 - 690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Henningfield
Nicotine Medications for Smoking Cessation
N. Engl. J. Med.,
November 2, 1995;
333(18):
1196 - 1203.
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 1992
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|